• Corpus ID: 250536807

Comparison of Two High-Throughput Reverse Transcription-Polymerase Chain Reaction 1 Systems for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 2

@inproceedings{Craney2020ComparisonOT,
  title={Comparison of Two High-Throughput Reverse Transcription-Polymerase Chain Reaction 1 Systems for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 2},
  author={Arryn Craney and Priya D. Velu and Michael J. Satlin and Kathy A. Fauntleroy and Katrina Callan and Amy E. Robertson and Laura Spina and Beryl Lei and Anqi Chen and Tricia Alston and Anna Rozman and Massimo Loda and Hanna Rennert and Melissa and Cushing and Lars F Westblade},
  year={2020}
}
27 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as the cause of a 28 worldwide pandemic. Many commercial SARS-CoV-2 reverse transcription-polymerase chain 29 reaction (RT-PCR) assays have received Emergency Use Authorization from the United States 30 Food and Drug Administration. However, there are limited data describing their performance, in 31 particular the performance of high-throughput SARS-CoV-2 RT-PCR systems. We analyzed the 32 diagnostic performance of two… 

Tables from this paper

Performance characteristics of a high throughput automated transcription mediated amplification test for SARS-CoV-2 detection

TLDR
Analytical and clinical performance characteristics of a new, high throughput, fully automated nucleic acid amplification test system for the detection of SARSCoV2 and validation evidence for a sensitive and specific method for pandemic-scale automated molecular diagnostic testing for SARSCeV2 is reported.

Rapid implementation of SARS-CoV-2 emergency use authorization RT-PCR testing and experience at an academic medical institution

TLDR
It is demonstrated that the assay accurately and sensitively identifies SARS-CoV-2 in multiple specimen types in the clinical setting and summarizes clinical data from early in the epidemic in New York City.

Distribution of SARS-CoV-2 PCR Cycle Threshold Values Provide Practical Insight Into Overall and Target-Specific Sensitivity Among Symptomatic Patients

TLDR
Based on the distribution of observed CT values, including the small proportion of specimens with values near the assay LoD, there is a low risk of false-negative RT-PCR results in combined nasopharyngeal-oropharynGEal specimens obtained from symptomatic individuals.

Repeated Coronavirus Disease 2019 Molecular Testing: Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Culture With Molecular Assays and Cycle Thresholds

TLDR
Low Ct values in SARS-CoV-2 diagnostic tests were associated with virus growth in cell culture, and whole-genome sequencing provided evidence the same virus was carried over time.

Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019

TLDR
Admission SARS-CoV-2 viral load among hospitalized patients with COVID-19 independently correlates with the risk of intubation and in-hospital mortality and could potentially be used to guide patient care.

Repeat COVID-19 Molecular Testing: Correlation of SARS-CoV-2 Culture with Molecular Assays and Cycle Thresholds.

TLDR
Low Ct values in SARS-CoV-2 diagnostic tests were associated with virus growth in cell culture, and Symptomatic patients with prolonged viral RNA shedding can also be infectious.

SARS-CoV-2 pandemic: a review of molecular diagnostic tools including sample collection and commercial response with associated advantages and limitations

TLDR
This work puts forth key observations in the functionality of current methods for SARS-CoV-2 diagnostic testing, which include nucleic acid amplification–, CRISPR-, sequencing-, antigen-, and antibody-based detection methods.

The Main Molecular and Serological Methods for Diagnosing COVID-19: An Overview Based on the Literature

TLDR
The COVID-19 pandemic has highlighted the critical role of diagnostic technologies in the control of infectious diseases, and the main diagnostic approaches currently available for the diagnosis of SARS-CoV-2 infection in humans are summarized.

Impact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease 2019

  • Reed MaglebyL. Westblade M. Satlin
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2020
Abstract Background Patients hospitalized with coronavirus disease 2019 (COVID-19) frequently require mechanical ventilation and have high mortality rates, but the impact of viral burden on these

Routine laboratory blood tests predict SARS-CoV-2 infection using machine learning

TLDR
This model employing routine laboratory test results offers opportunities for early and rapid identification of high-risk SARS-COV-2 infected patients before their RT-PCR results are available, validating the generalization of its use.

References

SHOWING 1-4 OF 4 REFERENCES

Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19

TLDR
The types of tests available and how they might be useful in the face of a rapidly changing and never-before-experienced situation are explained.

Interrater reliability: the kappa statistic

TLDR
While the kappa is one of the most commonly used statistics to test interrater reliability, it has limitations and levels for both kappa and percent agreement that should be demanded in healthcare studies are suggested.

The 264 Detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and Roche 265 cobas SARS-CoV-2 assays

  • J Clin Microbiol Accepted Manuscript Posted Online
  • 2020